Accordingly, a recent study unveiled a novel metabolic function of MYC in regulation of fatty acid synthesis in prostate cancer, indicate that inhibition of fatty acid synthesis by targeting MYC ACLY/ACC1/FASN axis may be a viable strategy for prevention and/or therapy of prostate cancer(Singh et al. 2021). Here, ACLY is linked to prostate cancer.